Definitive Contract 75N93025C00018
Award Date
6/1/25
Potential Completion Date
5/31/27
Potential Value
$600K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Ampersand Biosciences LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
UPPER ST REG, NY 12945, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This is a $1,084,824.00 firm-fixed-price definitive contract awarded to Ampersand Biosciences LLC, a woman-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 30, 2024. The contract is for the further characterization and validation of monoclonal antibodies to study respiratory diseases. The work will be performed in Upper St Reg, NY 12945, USA and has an ultimate completion date of September 29, 2026. This contract does not have a set-aside...
This is a $1,497,384.00 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Avantgen Inc., a small business biotechnology company based in San Diego, California. The contract is for the development of rabbit monoclonal antibodies for use as ferret biomarkers. This contract is not associated with a larger contract vehicle and does not have a set-aside designation. Avantgen Inc. has previously been awarded multiple federal...
This is a $356,021 firm-fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Avantgen Inc., a San Diego-based biotechnology company. The contract is for the development of rabbit monoclonal antibodies for ferret biomarkers. This work is set aside for small businesses. Avantgen has previously received NIH contracts to develop rapid diagnostic...
This is a $2,517,650 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Battelle Memorial Institute. The contract is for the "SIDE-BY-SIDE EVALUATION OF FOUR ANTI-PROTECTIVE ANTIGEN MONOCLONAL ANTIBODIES IN THE NHP ADDED BENEFIT ANIMAL MODEL" and is issued under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ contract vehicle. Battelle will be the...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
This is a $600,000.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Proteovista LLC, a woman-owned small business. The contract has a total small business set aside designation. The contract is for the development of aptamers (short, synthetic nucleic acid molecules) to recognize Nod-like receptors in zebrafish. Nod-like receptors play a key role in the innate immune system's...
<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Affymetrix, Inc. for the delivery of antibodies. The contract has a ceiling value of $7,771.50 and a completion date of August 28, 2015. The contract was not set aside for any specific business type. As a manufacturer of goods, Affymetrix, Inc. is the prime contractor for this award.</p>
This is a $4,590,862.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Sorrento Therapeutics, Inc., a small disadvantaged business. The contract is for the "DEVELOPMENT OF IN VITRO FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES", which was a Broad Agency Announcement (BAA) research area. The contract has a period of performance through May 2, 2025...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $28,590.00 firm fixed-price purchase order contract to Abveris, Inc. to provide hybridoma generation cell panel services using mice. This sole-source contract was issued under the authority of 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1, as no other source could provide the required proprietary Abveris hyperimmune DiversimAb mice and associated services. The contract...